文献库搜索 | GeneLibs

Chi(C),Li(L),Xu(C) Onco Targets Ther None

...mOS reached up to 5.4 months (95% CI, 4.4-6.4 months) and 11.2 months (95% CI, 7.2-15.2 months), respectively. In the gr...

Tasneem(Z),Zhao(Y),Fröch(JE),Majumdar(A),V... ACS Photonics 2026-04-01

...MOs), the parameters of which are optimized in an end-to-end fashion using a differentiable look-up table for the MO and...

Kewan(T),Alkabbani(O),Zureigat(H),He(R),Je... Blood Neoplasia 2026-05-00

...mOS) was 15.7 months. Each system stratified mOS (all P < .001); overall c-index favored ELN 2022 (0.640) and Beat AML 2...

Kostanova(A),Shamsiyeva(Y),Yermukhanov(A),... Front Microbiol None

...MOS), derived from cereal biomass, are particularly promising due to their structural stability, low effective dosages, ...

Frnda(J),Rozhon(J),Uhrina(M),Bienik(J),Voz... Sci Rep 2026-04-06

...MOS). The absence of a standardized conversion from objective VQA methods to MOS poses challenges for consistency and co...

Jiang(S),Yan(J),Nie(Y),Zhan(H),Lü(C) Commun Eng 2026-04-07

...MoS₂, diamane) for mechanical energy storage, offering an eco-friendly alternative to conventional electrochemical syste...

Guo(W),Li(Y),Dai(L),Jia(Y),Tong(M),Li(J),J... BMC Pulm Med 2026-04-06

...mOS was better.The RCT indicated that continuous ICI treatment was better than a 1-year fixed regimen in mPFS, mOS, 1-ye...

Yang(Y),Yu(K),Yang(F),Sapelkin(A),Lin(J),Z... Small 2026-05-00

...Mos), which grew onto the core QD. Our work brings compelling evidence of the molecule-PNC-Mo-shell transition pathway, ...

Gong(C),Shi(S),Zhang(Z),Zhao(Z),Liu(Z),Wan... BMC Musculoskelet Disord 2026-04-07

...MoS₂ composites substantially reduced Escherichia coli counts, with the PMMA + 5%MoS₂ composite exhibiting the most pote...

Ma(R),Liu(X),Gong(R),Jiang(Y) Discov Oncol 2026-04-08

...MOS prognostic genes and construct a prognostic risk model. Subsequently, receiver operating characteristic (ROC) curve ...